T1	Participants 966 1085	54 patients with biopsy-proven chronic glomerulonephritis, hypertension and normal or slightly impaired kidney function
T2	Participants 1735 1845	patients receiving combined therapy in comparison with losartan treatment after 3 months of therapy (p = 0.02)
